Skip to content

Long Non-Coding RNA LINC01020 as Novel Players in patients with schizophrenia and predict treatment response to antipsychotic medication

Long Non-Coding RNA LINC01020 as Novel Players in patients with schizophrenia and predict treatment response to antipsychotic medication

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000033024
Enrollment
Unknown
Registered
2020-05-18
Start date
2020-06-01
Completion date
Unknown
Last updated
2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

schizophrenia

Interventions

schizophrenia:Standardized antipsychotic treatment for 12 weeks

Sponsors

The Fourth People's Hospital of Zhang-Jia-Gang
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The schizophrenia group comes from the outpatient or inpatients of The Fourth Peoples Hospital of Zhang-Jia-Gang: 1. according to the fourth edition of The Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) and the tenth edition of the International Classification of Diseases and Related Health Problems (ICD-10) Diagnostic criteria for schizophrenia; 2. patients who did not take antipsychotic drugs or stopped treatment for more than 6 months before enrollment; 3. aged 18 to 45 years; 4. total score of positive and negative symptoms scale (PANSS) >=60 point. The control group came from community health volunteers in Zhang'jia'gang City: 1. After detailed interviews and complete physical and laboratory examinations, it was confirmed that there were no major physical diseases or genetic diseases; 2. Age, gender match with case group.

Exclusion criteria

Exclusion criteria: Exclusion criteria: (1) current or previous diagnosis of other mental illnesses in accordance with ICD-10 in addition to schizophrenia; (2) chronic organic diseases of the central nervous system; (3) risk of suicide or self-mutilation, Or other corresponding characteristics; (4) history of gastrointestinal surgery, or there may be conditions that may interfere with the absorption, distribution, metabolism, or excretion of the drug; (5) use of long-acting antipsychotic drugs within the past month and have received electroconvulsive shock Treatment (MECT), or transcranial magnetic stimulation therapy; (6) Severe physical diseases; (7) Women during pregnancy and lactation. Exclusion criteria for the healthy control group: 1. have a history of mental illness and family history of mental illness; 2. have a history of hypertension, diabetes, heart disease and other chronic diseases; 3. history of drug use or alcohol dependence; 4. women during pregnancy and lactation.

Design outcomes

Primary

MeasureTime frame
LINC01020;

Countries

China

Contacts

Public ContactWU Yajuan

The Fourth People's Hospital of Zhang-Jia-Gang

wuyajuan0210@126.com+86 18862315359

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026